Home
HelpTest ID BLOD1138 Histamine Release-Chronic Urticaria
Specimen Type/Requirements
Red top (Serum w/out gel) tube - Serum
Patients taking calcineurin inhibitors should stop taking their medication for 72 hours prior to draw.
Test is affected by hemolysis and lipemia.
Specimen Volume
| Preferred Volume | 1.5 mL |
|---|---|
| Minimum Volume | 1.0 mL |
Stability/Transport
| Room Temperature | 7 days | |
|---|---|---|
| Refrigerated | 7 days | Preferred for transport |
| Frozen | 30 days |
Performed Test Frequency
Tuesday, Thursday
Methodology
Cell Culture, Immunoassay
Performing Lab
Quest Chantilly forwards to Quest San Juan Capistrano
Additional Information
Includes Histamine Release (Chronic Urticaria)
Coverage Limitations
This test has limited coverage - please submit Commercial Insurance Patient Waiver (Non-Medicare) if applicable.
AKA
Anti-IgE Receptor Chronic Urticaria
FCER1
FFC Epsilon Receptor Antibody
CU (Chronic Urticaria)
CPT
86343
Report Available
4 - 9 days
Interface Build Information
| Result Code | Result Code Description |
|---|---|
| 8636 | Histamine Release (Chronic Urticaria) |
| 8766 | Result Received Histamine Release |